Status:
COMPLETED
The Future of Revascularization Using a Bioprotec Graft
Lead Sponsor:
Hôpital NOVO
Conditions:
Peripheral Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is the rate assessment of rescued limbs, one year after a BIOPROTEC vascular graft.
Detailed Description
The BIOPROTEC grafts are controverted: they are useful in some cases, but they are known as frequently broken or thrombosed. However they are always posed in a complicated situations, in a fragile pat...
Eligibility Criteria
Inclusion
- ≥ Eighteen years old.
- Critical ischemia (Phase 4-6 of Rutherford): no saphenous equipment for the vascular reconstruction; at least one leg axis permeable.
Exclusion
- Pregnant woman.
- Patient with an acute ischemia.
- Patient with an exceeded ischemia.
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 7 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04018846
Start Date
September 1 2018
End Date
October 7 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cntre Hospitalier René Dubos
Cergy-Pontoise, France